Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | Taselisib |
Trade Name | |
Synonyms | RG7606|GDC-0032|RG-7604|RO5537381 |
Drug Descriptions |
Taselisib (GDC-0032) is a beta isoform-sparing PI3K inhibitor, with greater activity against oncogenic mutants of PIK3CA (PMID: 23662903, PMID: 31439579). |
DrugClasses | PIK3CA inhibitor 21 PIK3CD inhibitor 27 PIK3CG inhibitor 10 |
CAS Registry Number | 1282512-48-4 |
NCIT ID | C116876 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
AZD6482 + Taselisib | AZD6482 Taselisib | 0 | 0 |
Docetaxel + Taselisib | Docetaxel Taselisib | 0 | 1 |
Enzalutamide + Taselisib | Enzalutamide Taselisib | 0 | 1 |
Everolimus + Taselisib | Everolimus Taselisib | 0 | 0 |
Fulvestrant + Palbociclib + Taselisib | Fulvestrant Palbociclib Taselisib | 0 | 0 |
Fulvestrant + Taselisib | Fulvestrant Taselisib | 0 | 1 |
Letrozole + Taselisib | Letrozole Taselisib | 1 | 0 |
Neratinib + Taselisib | Neratinib Taselisib | 0 | 0 |
Paclitaxel + Taselisib | Paclitaxel Taselisib | 0 | 1 |
Palbociclib + Taselisib | Palbociclib Taselisib | 2 | 0 |
Radiotherapy + Taselisib | Radiotherapy Taselisib | 3 | 0 |
Tamoxifen + Taselisib | Tamoxifen Taselisib | 0 | 0 |
Taselisib | Taselisib | 23 | 5 |
Taselisib + USP7-797 | Taselisib USP7-797 | 0 | 0 |